Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [ 18 F]FDG PET and acidoCEST MRI
Conclusions[18F]FDG PET and acidoCEST MRI studies can be performed simultaneously. The synergistic combination of assessing glucose uptake and tumor acidosis can improve differentiation of a drug-treated group from a control group during drug treatment of a tumor model.
Source: Molecular Imaging and Biology - Category: Molecular Biology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Fortamet | Metformin | Molecular Biology | MRI Scan | Pancreas | Pancreatic Cancer | PET Scan | Study